Gooch & Housego
PLC
("G&H" or the "Company" or the
"Group")
Full Year Trading
Update
and
Notice of
Results
Gooch & Housego PLC (AIM: GHH),
the specialist manufacturer of photonic components & systems,
announces its trading update for the financial year ended 30
September 2024. Trading in the second half of the financial year
has been strong compared with the first half and is in line with
current market expectations.
Trading Update
The Group is pleased to report that,
as expected, trading levels improved during the second half of the
year.
In our Industrial markets, volumes
of our fibre optic modules and assemblies used in both advanced
lithography systems and subsea data networks grew in the second
half compared with the first half of the year, as programmes
migrated to volume production. However, revenues from our
industrial laser customers remained broadly flat compared with the
first half of the year. Whilst there are early signs of a pick-up
in demand, we expect a sustained recovery from our broader
industrial laser and semiconductor markets in the second half of
the coming calendar year.
In our Aerospace and Defence
business there was second half revenue growth from deliveries of
precision optics and advanced sighting systems into both air and
land miliary platform programmes. In the commercial aerospace
market demand for our ring laser gyro components continues to be
strong and we are now benefiting from the additional capacity we
have added to meet increasing demand.
Volumes from our Ashford facility
for medical diagnostic instruments increased in the second half of
the year owing to the phasing of customers' programmes. Our
Life Sciences R&D team remains fully engaged in supporting
customers with the design and accreditation of their next
generation instruments which are expected to convert to production
revenues for the Group in the coming years. Deliveries into our
medical laser customers saw some recovery in the second half as the
prolonged destocking cycle that we have experienced is
ending.
Thanks to the stronger trading
performance in the second half the Board expects the Group to
deliver full year revenue and adjusted pre-tax profit in line with
current market expectations.
Cash
Cash generation in the second half
of the financial year has been good and the Group has been able to
reduce its borrowing by $3.9m. Net debt (pre-IFRS 16) at the
financial year end is, therefore, expected to be slightly better
than market expectations.
Outlook
As at 30 September 2024 the Group's
order book stood at £104.5m (30 September 2023: £115.3m after
adjusting for the divestment of the EM4 business). On an organic
constant currency basis the order book declined by 5% during
FY2024, partially due to a further £1.4m reduction in the Group's
past due backlog and from the timing of orders for our medical
diagnostic instruments. Our order book for medical laser devices
has also declined but we are now starting to see evidence of the
start of a recovery from this market. In our industrial
markets, whilst the destocking patterns we saw in the first half of
the year are now behind us, we have not yet seen sustained recovery
in the industrial laser market.
Offsetting these declines our
Aerospace and Defence order book has grown strongly in the
financial year thanks to increased demand from both our commercial
and defence customers assisted by the enhanced value proposition we
are able to offer. Our teams in the UK and US are focused on
converting a healthy pipeline of new Aerospace and Defence
prospects.
Notice of Results
The Company will announce its
audited results for the year ended 30 September 2024 on 3 December
2024.
Charlie Peppiatt, Chief Executive
Officer of Gooch and Housego, commented:
"Following the first half result, the Group recovered well in
the second half to deliver the expected increase in
output.
"Whilst we do not expect to see our industrial laser and
semi-conductor markets return to growth until next year, we are
seeing strong demand for our advanced optical systems capabilities
from the defence sector and there are significant new business
opportunities that we are working hard to secure.
"We continue to make progress on delivering the self-help,
technology and portfolio activities that underpin our strategic
plan. We saw further improvement with on time delivery performance
in FY2024 and customer feedback is now trending in a positive
direction.
"The Group is now better positioned to benefit from the
anticipated sustained recovery from our end markets next year
thanks to the disciplined implementation of our
strategy."
For
further information please contact:
Charlie Peppiatt, Chief Executive
Officer
Chris Jewell, Chief Financial
Officer
|
Gooch & Housego PLC
|
+44 (0) 1460 256440
|
|
|
|
Mark Court / Sophie Wills/ Abigail
Gilchrist
G&H@buchanan.uk.com
|
Burson Buchanan
|
+44 (0) 20 7466 5000
|
|
|
|
Christopher Baird / David
Anderson
|
Investec Bank plc
|
+44 (0) 20 7597 5970
|
Notes to editors
1. Gooch
& Housego is a photonics technology business headquartered in
Ilminster, Somerset, UK with operations in the USA and Europe. A
world leader in its field, the company researches, designs,
engineers and manufactures advanced photonic systems, components
and instrumentation for applications in the Aerospace &
Defence, Industrial, Life Sciences and Scientific Research sectors.
World leading design, development and manufacturing expertise is
offered across a broad range of complementary
technologies.
2. All
financial information included in this announcement is sourced from
unaudited management accounts and excludes any specific items. This
announcement contains certain forward-looking statements that are
based on management's current expectations or beliefs as well as
assumptions about future events. These are subject to risk
factors associated with, amongst other things, the economic and
business circumstances occurring from time to time in the countries
and sectors in which G&H operates. It is believed that
the expectations reflected in these statements are reasonable but
they may be affected by a wide range of variables which could cause
actual results, and G&H's plans and objectives, to differ
materially from those currently anticipated or implied in the
forward-looking statements. Investors should not place undue
reliance on any such statements. Nothing in this announcement
should be construed as a profit forecast.